¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"serum prothrombin conversion accelera"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® prothrombin time ÇÑ±Û ÇÁ·ÎÆ®·Òºó½Ã°£
¼³¸í   
  ÇÁ·ÎÆ®·ÒºóÀº °£¿¡¼­ ÇÕ¼ºµÇ´Â ºñŸ¹Î K ÀÇÁ¸¼º ÀÀ°í´Ü¹éÁúÀÇ ÇϳªÀ̸ç, ÇÁ·ÎÆ®·Òºó½Ã°£Àº ¿ÜÀΰè ÀÀ°íȰ¼ºÀ» Á¾ÇÕÀûÀ¸·Î Æ¯Á¤Çϴ °Ë»çÀÇ ÇϳªÀÌ´Ù. ÇǰËÇ÷Àå¿¡ Ä®½·À̿°ú Á¶Á÷Æ®·Òº¸ÇÃ¶ó½ºÆ¾(Á¦III ÀÀ°íÀÎÀÚ)À» °¡ÇØ, ¼¶À¯¼Ò°¡ ³ªÅ¸³¯ ¶§±îÁöÀÇ ½Ã°£À¸ ÃøÁ¤ÇÑ´Ù.
¿µ¹® conversion ÇÑ±Û Àüȯ
¼³¸í   
  1. ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °Í. 2. ¾î¶² º´À̳ª ¹ÝÀÀÀÌ ÇÑ »óÅ¿¡¼­ ´Ù¸¥ »óÅ·Πº¯Çϴ °Í.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
¿µ¹® serum ÇÑ±Û Ç÷û
¼³¸í   
  Ç÷¾×ÀÇ ¼ººÐ Áß °íÇü¼ººÐÀΠÇ÷±¸¼¼Æ÷(ÀûÇ÷±¸, ¹éÇ÷±¸ µî), Ç÷¼ÒÆÇÀ» Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ÀåÀ̶ó°í Çϰí, Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¸¦ Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ûÀ̶ó°í ÇÑ´Ù.
¿µ¹® serum proteins ÇÑ±Û Ç÷û´Ü¹é
¼³¸í   
  Ç÷û¿¡ Àִ ´Ü¹éÁúµéÀ» ÃÑĪÇϴ ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©Çϴ Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • conversion disorder
    ÀüȯÀå¾Ö
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • digital scan conversion
    µðÁöÅнºÄµÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • hysterical conversion
    È÷½ºÅ׸®Àüȯ
  • internal conversion
    ³»ºÎº¯È¯
  • positive conversion
    ¾ç¼ºÀüȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • conversion
    Àüȯ
  • peripheral conversion
    ¸»ÃÊÀüȯ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • serum hepatitis
    Ç÷û°£¿°
  • serum
    Ç÷û
  • serum sickness
    Ç÷ûº´
  • serum typing
    Ç÷ûÇü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • congenital conversion nipple
    ¼±ÃµÀüȯÀ¯µÎ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • gene conversion
    À¯ÀüÀÚº¯È¯
  • hysterical conversion
    È÷½ºÅ׸®Àüȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SPCA= serum prothrombin conversion a
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüÈ­ÃËÁø¼Ò.
  • activated partial prothrombin time
    Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin complex concentrates
    ÇÁ·ÎÆ®·Òºó º¹ÇÕ ³óÃà(¹°)
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£.
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó ½Ã°£
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • gene conversion
    À¯ÀüÀÚº¯È¯.
  • gene conversion
    À¯ÀüÀÚº¯È¯(ܨüµ).
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ.
  • hysterical conversion
    ÀüȯÈ÷½ºÅ׸®,È÷½ºÅ׸®Àüȯ(¡­ï®üµ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • serum prothrombin conversion accelera
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüȯÃËÁø¼Ò(úìôè¡­ï®üµõµòä
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activated partial prothrombin time
    Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • factor ii(prothrombin)
    Á¦2ÀÎÀÚ(ÇÁ·ÎÆ®·Òºó)
  • partial prothrombin time
    ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin complex concentrates
    ÇÁ·ÎÆ®·Òºó º¹ÇÕ ³óÃà(¹°)
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£.
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó ½Ã°£
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ(ï®üµ).
  • conversion disorder
    ÀüȯÀå¾Ö(ï®üµî¡äô)., Àüȯº´
  • conversion factor
    º¯È¯ ÀÎÀÚ
  • conversion heat
    Àüȯ¿­(ï®üµæð).
  • conversion neurosis
    Àüȯ½Å°æÁõ(ï®üµ ãêÌèñø)., Àüȯ½Å°æº´
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • serum prothrombin conversion accelerator
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÃËÁøÁ¦(ï®üµõµòäð¥)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • serum prothrombin converting factor
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÀÎÀÚ(ï®üµì×í­)
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin derivatives theory
    ÇÁ·ÎÆ®·Òºó À¯µµÃ¼ ÀÌ·Ð(ë¯Óôô÷×âÖå)
  • prothrombin factor
    ÇÁ·ÎÆ®·Òºó ÀÎÀÚ(ì×í­)
  • antigenic conversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ)
  • conversion
    Àüȯ(ï®üµ)
  • conversion coefficient
    Àüȯ°è¼ö(ï®üµÌõâ¦)
  • conversion electron
    ÀüȯÀüÀÚ(ï®üµï³í­)
  • conversion factor
    ÀüȯÀÎÀÚ(ï®üµì×í­)
  • conversion period
    Àüȯ±â°£(ï®üµÑ¢Êà)
  • conversion stage
    Àüȯ½Ã±â(ï®üµãÁÑ¢)
  • gene conversion
    À¯ÀüÀÚ Àüȯ(ë¶îîí­ï®üµ)
  • internal conversion
    ³»ºÎÀüȯ(Үݻï®üµ)
  • internal conversion electron
    ³»ºÎÀüȯ ÀüÀÚ(Үݻï®üµï³í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • conversion
    Àüȯ, º¯È¯, º¯Á¶, ÀüÈ­
  • conversion factor
    º¯È¯ÀÎÀÚ
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • direct conversion x-ray detector
    Á÷Á¢º¯È¯X¼±°ËÃâ±â
  • radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÈ­Ç÷û¾ËºÎ¹Î
  • serum
    Ç÷û
  • serum amylase
    Ç÷û¾Æ¹Ð¶ó¾ÆÁ¦
  • serum creatinine
    Ç÷ûũ·¹¾ÆÆ¼´Ñ
  • serum protein
    Ç÷û´Ü¹é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PPCA plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator
SPCA serum prothrombin conversion accelerator; Society for Prevention of Cruelty to Animals
PCF peripheral circulatory failure; pharyngoconjunctival fever; platelet complement fixation; posterior ...
PPC pentose phosphate cycle; peripheral posterior curve; plasma prothrombin conversion; pneumopericardiu...
PPCF peripartum cardiac failure; plasma prothrombin conversion factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
(14)C Conversion of
1-14C Conversion of
4-14C Conversion of
(14)C conversion of L
DC Degree of conversion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • partial prothrombin time
    ºÎºÐ ÇÁ·ÎÆ®·Òºó ½Ã°£
  • plasma prothrombin time
    Ç÷Àå ÇÁ·ÎÆ®·Òºó ½Ã°£
  • prothrombin consumption test
    ÇÁ·ÎÆ®·Òºó ¼Òºñ ½ÃÇè
    ³»Àμº Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÇ Çü¼º·® ÃøÁ¤À» ÁÖµÈ ¸ñÀûÀ¸·Î ÇÏ´Â ½ÃÇèÀ¸·Î, ÀÀÇ÷ ¿Ï·á ÈÄ¿¡ ³²¾Æ ÀÖ´Â Ç÷û ÇÁ·ÎÆ®·ÒºóÀ» ÃøÁ¤ÇÑ´Ù. ÀÌ ½ÃÇèÀº Àüü Ç÷¾×¿¡ ´ëÇÏ¿© ÇàÇϱ⠶§¹®¿¡, Ç÷¼ÒÆÇÀÇ ÀÀÇ÷ ±â´É ÃøÁ¤¿¡ °£Á¢ÀûÀ¸·Î »ç¿ëµÈ´Ù.
  • prothrombin test
    ÇÁ·ÎÆ®·Òºó ½ÃÇè
    ÀÀÇ÷ ½Ã°£¿¡ ±âÃÊÇÑ ÇÁ·ÎÆ®·Òºó °ËÃâ ½ÃÇè.
  • two-stage prothrombin test
    ÀÌ ´Ü°è ÇÁ·ÎÆ®·Òºó ½ÃÇè
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
  • conversion disorder
    Àüȯ Àå¾Ö
    1. ±âÁúÀû ÁúȯÀÌ ¾øÀÌ ¹«ÀǽÄÀûÀÎ ¿ä±¸³ª °¥µîÀ¸·Î ÀÎÇÑ °¨°¢À̳ª ¿îµ¿ ±â´ÉÀÇ Àå¾Ö°¡ Ư¡ÀÎ Á¤½Å Áúȯ. 2. ½Å°æÇÐÀû ¶Ç´Â ³»°úÀû ÁúȯÀÌ ¾øÀÌ ¸¶ºñ, ½Ã·Â »ó½Ç, ÇÔ±¸Áõ
  • conversion factor
    º¯È¯ °è¼ö
  • conversion rate
    ÀüȯÀ²
  • hysteria conversion
    Àüȯ È÷½ºÅ׸®, È÷½ºÅ׸® Àüȯ
    ºÒ¾ÈÀ» ½ÅüÀû ¡ÈÄ ¶Ç´Â Áõ»óÀ¸·Î Àüȯ½ÃÄÑ, ºÒ¾ÈÀ» ¹Ù²Ù¾î ³õ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â È÷½ºÅ׸®.
  • salt water conversion kit
    ¿°·ù º¯È¯ Ŷ
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • Banzhaf serum
    ¹ÝÃ÷ÇÏÇÁ Ç÷û
    ³óÃà Ç×Æó¿°±Õ Ç÷û.
  • Bardel's serum
    ¹Ù¾Æµ¨ Ç÷û
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
serum prothrombin conversion accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
proserum prothrombin conversion accelerator A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs.
(12 Dec 1998)
prothrombin Clotting Factor II.
Origin: Gr. Thrombos = cloth in
(18 Nov 1997)
prothrombin accelerator <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
prothrombin and proconvertin test A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs.
Synonym: P and P test.
(05 Mar 2000)
prothrombin deficiency A congenital or acquired disorder of blood clotting where there is a deficiency of factor II (prothrombin), one of 20 necessary plasma proteins for normal blood coagulation. Acquired factor II deficiency may result from vitamin K deficiency, severe liver disease and anticoagulant drugs.
Symptoms include abnormal bleeding, nosebleeds, abnormal menstrual bleeding, easy bruising and umbilical cord bleeding at birth. Treatment involves the infusion of fresh frozen plasma. Vitamin K may be administered in select cases.
(27 Sep 1997)
prothrombin test A quantitative test for prothrombin in the blood based on the clotting time of oxalated blood plasma in the presence of thromboplastin and calcium chloride; measures the integrity of the extrinsic and common pathways of coagulation.
See: prothrombin time.
Synonym: Quick's method, Quick's test.
(05 Mar 2000)
prothrombin time Measurement of clotting time of plasma recalcified in the presence of excess tissue thromboplastin. Factors measured are fibrinogen, prothrombin, and factors v, vii, and x. It is used for monitoring anticoagulant therapy with coumarins.
(12 Dec 1998)
analog-digital conversion The process of converting analog data such as continually measured voltage to discrete, digital form.
(12 Dec 1998)
bed conversion The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.
(12 Dec 1998)
biochemical conversion process The use of living organisms or their products to convert organic material to fuels.
(05 Dec 1998)
gene conversion <molecular biology> A phenomenon in which alleles are segregated in a 3:1 not 2:2 ratio in meiosis. May be a result of DNA polymerase switching templates and copying from the other homologous sequence or a result of mismatch repair (nucleotides being removed from one strand and replaced by repair synthesis using the other strand as template).
(18 Nov 1997)
plasmin prothrombins conversion factor <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
conversion An unconscious defense mechanism by which the anxiety that stems from intrapsychic conflict is converted and expressed in a symbolic somatic.
Origin: L. Con = with, versio = turning
(18 Nov 1997)
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
conversion electron An internal conversion electron.
(05 Mar 2000)
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 1 ÆäÀÌÁö: 1
  • serum prothrombin conversion accelerator - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó(ÀÀÇ÷ ÀÎÀÚÀÇ ÀÏÁ¾)
  • serum
    Ç÷û
  • immune serum
    ¸é¿ª Ç÷û
  • serum
    Àå¾×;Ç÷û
  • truth serum
    Áø½É Åä·Î¾à (¸ÔÀ¸¸é Áø½ÉÀ» Åоî³õ´Â´Ù´Â ¾à)
  • conversion
    Àüȯ; ÅÂȯ(ÅÂȯ)
  • conversion
    Àüȯ;ÀüÈ­(changing);(Áý.Â÷µîÀÇ)°³Àå;°³Á¶;º¯¼³;ÀüÇâ;°³Á¾;±ÍÀÇ (ƯÈ÷ ±âµ¶±³¿¡ÀÇ);(ÁÖ»ç¿Í ºó»ç¿ÍÀÇ)ȯÀ§(¹ý);(ºÎäÀÇ) Â÷ȯ;¹Ù²ãÁü;(ÁöÆóÀÇ)ÅÂȯ;(¿Ü±¹ÅëÈ­ÀÇ)ȯ»ê;ÀÌÀÚ¸¦ ¿ø±Ý¿¡ °¡»êÇϱâ;(Àç»êÀÇ)Àüȯ;(µ¿»êÀÇ)Ⱦ·É;Àüȯ(ÇÙ¿¬·á¹°ÁúÀÌ ´Ù¸¥ ÇÙ¿¬·á¹°Áú·Î º¯È­Çϱâ);~al;
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • conversion factor
    (¹®ÀÇ.ÀÚ·áû±¸¿¡¼­ ½ÇÁ¦ »óǰ±¸¸ÅÀÎÀ¸·ÎÀÇ)ÀüȯÀ²
  • conversion heater
    Àü¿­±â(electric heater)
  • conversion ratio
    Àüȯ ºñÀ²(Çٺп­½Ã ÇϳªÀÇ ¿øÀÚ¿¡¼­ »ý±â´Â ¿øÀÚÀÇ ¼ö
  • conversion table
    (µµ·®ÇüµîÀÇ)ȯ»êÇ¥
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á